Compliance

Bio-Rad’s FCPA Settlement and the Russian Pharmaceutical Market

Bio-Rad’s FCPA Settlement and the Russian Pharmaceutical Market

Bio-Rad has recently settled DOJ and SEC investigations into alleged FCPA violations, to the tune of $55 million. The U.S. company found itself in hot water after having allegedly made improper payments to Russian government officials. Russia is a notoriously difficult market to navigate when compliance is at stake, but the pharmaceutical industry may have a tougher go of it...

Is the Cloud a Compliance Nightmare?

Is the Cloud a Compliance Nightmare?

If not done correctly, using the cloud to store sensitive data can create a headache for compliance professionals at best, and major lapses in security at worst. Make sure you know where information is being stored, how and by whom it's accessed and just how tight security measures are on the service provider's end. Maintaining security requires a joint effort...

The State of Whistleblowers

The State of Whistleblowers

The latest SEC Whistleblower report has been released, and it seems 2014 was a banner year for whistleblower investigations and awards. The number of awards issued was at its highest level yet and the magnitude of those awards on average was larger than ever as well. Given that whistleblowing is way up, employers would do well to ensure they handle...

Asia Pacific Anti-Corruption Rankings for 2014

Asia Pacific Anti-Corruption Rankings for 2014

Transparency International's Corruption Perceptions Index is out for 2014, and some of the changes from last year to this are notable. What's especially enlightening this year, however, is comparing the CPI with the new TRACE Matrix, which draws its data from more sources and reviews more countries worldwide. Read on for more detail on where Asia-Pacific countries stand.

Seamus Heaney and Compliance With a Seat at the Table

Seamus Heaney and Compliance With a Seat at the Table

When assessing compliance challenges ahead of an expansion into a new market, the CCO or compliance practitioner has quite the job on his or her hands. Tom Fox offers up four basic questions to consider when walking through analysis, third-party due diligence and developing a plan to ensure ongoing compliance both with the FCPA and any in-country regulatory requirements.

Compliance Attitudes in High-Risk Markets

Compliance Attitudes in High-Risk Markets

That a certain market is high-risk is no reason not to do business there. If entering into the Russian or Chinese market, for example, can be financially advantageous, your CCO ought to be able to develop a program and budget to prevent and detect violations there. The catch is that the CCO must be involved in the discussions regarding whether...

The Hidden Nexus Between Compliance and Reputation

The Hidden Nexus Between Compliance and Reputation

The health care industry has been no stranger to the consequences - reputational and financial - of non-compliance over the past few years. The entities that have managed to maintain good standing with the OIG have also enjoyed a continued positive public reputation. Those that have been found guilty of significant infractions (GSK, Johnson & Johnson, Stryker) are paying dearly.

Consequences of a Data Breach: Lessons from Wyndham Worldwide

Consequences of a Data Breach: Lessons from Wyndham Worldwide

Between 2008 and 2010, Wyndham was subject to three data breaches, exposing more than 600,000 of its consumers and leading to millions in fraud loss. Its shareholders filed action against the Board earlier this year, alleging negligence, and a decision (dismissal) was reached in late October. Though Wyndham's leadership was not ultimately held liable in this case, there's much to...

Page 101 of 111 1 100 101 102 111